Leemskuilen 18, B-2350 Vosselaar, Belgium.
Molecules. 2010 Jun 9;15(6):4129-88. doi: 10.3390/molecules15064129.
This review provides a historical overview of the analog based drug discovery of miconazole and its congeners, and is focused on marketed azole antifungals bearing the generic suffix "conazole". The antifungal activity of miconazole, one of the first broad-spectrum antimycotic agents has been mainly restricted to topical applications. The attractive in vitro antifungal spectrum was a starting point to design more potent and especially orally active antifungal agents such as ketoconazole, itraconazole, posaconazole, fluconazole and voriconazole. The chemistry, in vitro and in vivo antifungal activity, pharmacology, and clinical applications of these marketed conazoles has been described.
这篇综述提供了咪康唑及其同系物基于类似物的药物发现的历史概述,重点是市售的带有通用后缀“康唑”的唑类抗真菌药物。咪康唑是最早的广谱抗真菌药物之一,其抗真菌活性主要限于局部应用。体外抗真菌谱的吸引力是设计更有效、特别是具有口服活性的抗真菌药物的起点,如酮康唑、伊曲康唑、泊沙康唑、氟康唑和伏立康唑。本文描述了这些市售康唑的化学、体外和体内抗真菌活性、药理学和临床应用。